Related Experiment Video
Updated: Aug 26, 2025

Detection of Inflammasome Activation and Pyroptotic Cell Death in Murine Bone Marrow-derived Macrophages
Published on: May 21, 2018
NLRP3 inflammasome: The rising star in cardiovascular diseases
Yidan Zheng1, Li Xu1, Nianguo Dong1
1Department of Cardiovascular Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Insights
The nucleotide oligomerization domain-, leucine-rich repeat-, and pyrin domain-containing protein 3 (NLRP3) inflammasome drives cardiovascular disease progression and inflammation. Targeting NLRP3 inflammasome offers potential therapeutic strategies for these prevalent global diseases.
Area of Science:
- Cardiovascular Diseases
- Innate Immunity
- Inflammasome Biology
Background:
- Cardiovascular diseases (CVDs) are the leading global cause of mortality.
- Inflammasome activation, particularly NLRP3 inflammasome, is implicated in CVD pathogenesis.
- NLRP3 inflammasome mediates inflammatory responses and programmed cell death (pyroptosis).
Purpose of the Study:
- To review the role of NLRP3 inflammasome in various cardiovascular diseases.
- To discuss the mechanisms by which NLRP3 inflammasome contributes to CVD.
- To explore potential therapeutic interventions targeting the NLRP3 inflammasome pathway.
Main Methods:
- Literature review synthesizing current research on NLRP3 inflammasome in CVD.
- Analysis of studies detailing NLRP3 inflammasome activation and downstream effects.
- Discussion of therapeutic strategies targeting NLRP3 inflammasome components or activity.
Main Results:
- NLRP3 inflammasome activation is a key driver in atherosclerosis, myocardial infarction, heart failure, and other CVDs.
- NLRP3 inflammasome promotes inflammation through IL-1 family cytokine release and pyroptosis.
- Evidence supports NLRP3 inflammasome's significant role in the inflammatory cascade of cardiovascular pathologies.
Conclusions:
- The NLRP3 inflammasome is a critical mediator of inflammation and cell death in cardiovascular diseases.
- Understanding NLRP3 inflammasome function provides insights into CVD pathogenesis.
- Targeting the NLRP3 inflammasome presents a promising therapeutic avenue for managing cardiovascular diseases.
Abstract:
Cardiovascular diseases (CVDs) are the prevalent cause of mortality around the world. Activation of inflammasome contributes to the pathological progression of cardiovascular diseases, including atherosclerosis, abdominal aortic aneurysm, myocardial infarction, dilated cardiomyopathy, diabetic cardiomyopathy, heart failure, and calcific aortic valve disease. The nucleotide oligomerization domain-, leucine-rich repeat-, and pyrin domain-containing protein 3 (NLRP3) inflammasome plays a critical role in the innate immune response, requiring priming and activation signals to provoke the inflammation. Evidence shows that NLRP3 inflammasome not only boosts the cleavage and release of IL-1 family cytokines, but also leads to a distinct cell programmed death: pyroptosis. The significance of NLRP3 inflammasome in the CVDs-related inflammation has been extensively explored. In this review, we summarized current understandings of the function of NLRP3 inflammasome in CVDs and discussed possible therapeutic options targeting the NLRP3 inflammasome.
Related Concept Videos
Inflammation
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Coronary Artery Disease I: Introduction
Myocarditis I: Introduction
Rheumatic Heart Disease I: Introduction

